Impact of time‐varying confounders on the association between early‐life allergy sensitization and the risk of current asthma: A post hoc analysis of a birth cohort
Authors: Arthur H. Owora, Rui Li, Robert S. Tepper, Clare D. Ramsey, Moira Chan‐Yeung, Wade T. A. Watson, Allan B. Becker
Journal: Allergy (2022)

Existing literature on the relationship between early-life (first year of life) allergy sensitization and risk of childhood asthma is mixed.1, 2 This is in part due to the use of statistical analytic methods that ignore changes in both allergy sensitization status and asthma-related treatment exposure that may influence future asthma risk as a child grows older. Our recent disease transition models show that both childhood allergy sensitization and current asthma states (and plausibly related treatment) are time-varying, and the likelihood of a feedback loop cannot be ruled out3; this underscores the analytic challenges associated with evaluating to what extent early-life allergy sensitization may be causally related to childhood asthma development. Moreover, it is unclear if early-life allergen avoidance prevents or merely delays the onset of current asthma into adolescence or adulthood.4 In contrast to traditional discrete-time and longitudinal models (e.g., Generalized Estimating Equations—GEE) used in previous research,1, 2 Marginal Structural Models (MSM) can be used to adjust for time-varying confounding to produce consistent average causal effect estimands.5 Previous simulation studies have demonstrated the superiority of the MSM over traditional longitudinal statistical methodology.5 In this study, we hypothesize that among infants genetically predisposed to asthma, early-life allergy sensitization is associated with an increased risk of current asthma but this risk can be attenuated by allergen avoidance. We carried out a post hoc analysis using the MSM approach to estimate the average causal effect of early-life allergy sensitization and allergen avoidance on the risk of current asthma under the context of dynamic (changing) allergy sensitization-current asthma states in the Canadian Asthma Primary Prevention Study (CAPPS).6 CAPPS was a multifaceted intervention designed to decrease exposure in the first year of infancy to indoor aeroallergens such as house dust mites and pets and to encourage prolonged breastfeeding and delayed introduction of milk and solid foods.6 Current asthma and allergy sensitization were based on a pediatric allergist's clinical decision and skin prick test results, respectively, at age 1-, 2-, 7-, and 15-years. Briefly, MSMs are estimated using an inverse-probability-of-treatment (or exposure) weighted approach5 to remove the effects of time-varying confounders (i.e., post-baseline allergy sensitization and asthma-related treatment states) in the pathway between early-life sensitization and subsequent risk of current asthma (see Appendix S1 for details). The prevalence of current asthma and allergy sensitization varied during follow-up with and without CAPPS exposure (Figures 1, S1 and S2). The prevalence of current asthma did not differ between children sensitized to aeroallergens vs. food allergens in the first 2 years; however, during the 7th and 15th years, the odds of current asthma were six and four-fold higher among children sensitized (vs. un-sensitized) to food and aeroallergens, respectively (Figure S2). These results suggest different profiles of allergy sensitization (define by type and age) may differentially influence or modify the propensity of school-age asthma development. Our MSM model results (Table 1) showed that the odds of current asthma were higher among children with (vs. without) an early-life allergy sensitization (adjusted odds ratio [aOR]: 3.02; 95% CI: 1.51, 6.01) at age 7-years; however, no differences were observed at 15-years (aOR: 2.32; 95% CI: 0.78, 6.85). In contrast, the GEE model results overestimated the strength of this association by 49% at 7-years (aOR: 4.50; 95% CI: 2.53, 8.00) and incorrectly estimated its precision at 15-years (aOR: 2.03; 95% CI: 1.02, 4.04). Overall, the odds of current asthma were lower among children randomized to the CAPPS intervention (aOR: 0.69; 95% CI: 0.51, 0.93). Female children had 28% lower odds of current asthma than male children (aOR: 0.72; 95% CI: 0.53, 0.98). Our results suggest that early life is an etiologically critical window during which allergy sensitization may induce pathogenesis towards school-age asthma onset irrespective of whether the pattern of sensitization is transient or persistent. Conversely, allergen avoidance during this period may reduce the risk of current asthma. Discrepancies between our GEE and MSM results for these competing risk and protective effects on current asthma suggest that confounding due to time-varying allergy sensitization states and asthma-related treatment exposure may explain some of the null associations reported in previous research.1, 2 This underscores the need to adjust for time-varying confounders when investigating the association between current asthma and suspected risk and protective factors under dynamic risk contexts. Our findings (i.e., allergy sensitization—current asthma induction period and early-life as a critical etiologic window with intervention potential) may be generalizable to both developed and less developed countries; however, interpretation of similar analyses in these heterogenous populations should not preclude an examination of potential effect moderation/modification by environmental factors. In the absence of randomized baseline exposures (e.g., allergy sensitization), MSMs hold promise for the elucidation of childhood asthma causal mechanisms needed to inform the timing and strategies for preventive intervention. We thank the Canadian Asthma Primary Prevention Study families, Meghan B. Azad, study coordinators (Rishma Chooniedass, RN, BN, CAE, Department of Pediatrics and Child Health, University of Manitoba; Marilyn Lilley, RN, Department of Pediatrics and Child Health, University of Manitoba; and Roxanne Rousseau, BSc, CCRP, Department of Medicine, University of British Columbia), and the Canadian Asthma Primary Prevention Study research team, whose commitment and hard work have made this research possible. Open access funding enabled and organized by ProjektDEAL. All authors have no financial conflict of interest and nothing to disclose. Appendix S1 Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.